CEO DeGaynor Buys 170K RSUs, Signaling Confidence in Methode’s Turn‑Around

Insider Buying Signals a Renewed Confidence in Methode’s Turn‑Around

On September 22, 2026, CEO and President Jonathan B. DeGaynor added 15,000 restricted stock units (RSUs) to his portfolio and, shortly after, purchased a second tranche of 155,840 RSUs. The transaction was executed at a market price of $14.56, barely shy of the $14.83 close, and the trade generated a positive sentiment score (+49) and an unusually high buzz (≈1,082 %). In a sector where insiders often wait for a clearer valuation before committing capital, this timing suggests that De Gaynor believes the company’s recent restructuring and upcoming Investor Day are beginning to pay off.

Implications for Shareholders and the Bottom Line

Methode’s share price is up 7.7 % on the day, but the stock remains in a long‑term uptrend with a 91.6 % year‑to‑date gain. The company’s P/E ratio is negative (-13.08), reflecting heavy operating costs and R&D outlays typical of a manufacturing turnaround. The CEO’s RSU purchases, coupled with a flurry of insider buying across the board—over 30 recent trades by executives and senior managers—signal confidence that the company’s multi‑segment integration plan and margin‑improvement strategy will materialize. Investors may view this as a bullish cue, especially if the Investor Day confirms that the 2026 capital allocation plan will prioritize high‑margin automotive and industrial lines.

A Profile of DeGaynor’s Insider Activity

DeGaynor’s transaction history is a mix of sales and recent acquisitions. He sold 47,268 shares in early August at $16.67, 14,647 shares in late April at $8.02, and 7,986 shares in mid‑July at $15.76, reducing his stake to roughly 366,324 shares. Despite these sales, the CEO’s net ownership remains significant—about 9 % of the outstanding common stock—providing him with a tangible alignment to long‑term performance. His recent RSU purchases contrast with earlier sales, indicating a shift from liquidating positions to building equity exposure, a common pattern as a company’s prospects improve. Historically, DeGaynor has shown a willingness to lock in gains early but now appears to be positioning himself for upside as the company’s strategy unfolds.

What This Means for Investors

1. Confidence in Management – The CEO’s increased equity stake, coupled with other top executives’ buying, suggests internal conviction that the company’s pivot to higher‑margin segments will succeed.
2. Potential for Share Price Appreciation – Insider buying often precedes or coincides with positive corporate events. If the Investor Day confirms robust growth targets, the stock could see further gains, especially as the company moves from a negative P/E toward profitability.
3. Risk Factors Remain – Methode still operates in a cyclical industry with substantial capital needs. The negative earnings multiple and the high volatility of its stock price mean that investor sentiment could swing quickly if execution falters.

Bottom Line

The CEO’s recent RSU purchases, occurring amid a broader wave of insider buying, point to a growing belief among management that Methode’s transformation will deliver value. For investors, this insider activity is a positive signal that could precede a rally—provided the company’s announced strategy materializes and the Investor Day delivers credible traction.